Clinical Trial Update: Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to Lenalidomide [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating pomalidomide with cyclophosphamide and prednisone (PCP) in patients with relapsed/refractory multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• PREDNISONE (Prednisone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED